Skip to main content
SpringerLink
Log in

Efavirenz/emtricitabine/tenofovir disoproxil fumarate

Development of drug resistant mutation in HIV-1 infection: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Vancoillie L, et al. Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART. Antiviral Therapy 20: 789-794, No. 8, 2015. Available from: URL: http://doi.org/10.3851/IMP2966 - Belgium

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Efavirenz/emtricitabine/tenofovir disoproxil fumarate. Reactions Weekly 1633, 300 (2017). https://doi.org/10.1007/s40278-017-24568-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-24568-1

Search

Navigation